Overview

Investigating the Effectiveness of Eylea in Patients With Wet Age-related Macular Degeneration

Status:
Completed
Trial end date:
2017-03-31
Target enrollment:
Participant gender:
Summary
The study aims to investigate the effectiveness of Eylea in patients with wet age-related macular degeneration in routine clinical practice in Germany. The study is purely observational, only data from routine treatment are to be collected. The treatment and treatment conditions are solely at discretion of the treating physician.
Details
Lead Sponsor:
Bayer
Collaborator:
Regeneron Pharmaceuticals
Treatments:
Aflibercept